GSA CAPITAL PARTNERS LLP

Position in SEER — Seer, Inc.

CIK 1362033 LONDON, X0

Position in SEER

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$326,766

-$151,530 QoQ

Shares Held

194,504

-25.6% QoQ

Ownership

0.354%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $100,711,343 across 163 Biotechnology names. SEER ranks #95 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,831	$2,959,983
2	ARDX	Ardelyx, Inc.	473,061	$2,833,635
3	NTLA	Intellia Therapeutics, Inc.	178,301	$2,285,818
4	NUVB	Nuvation Bio Inc.	495,792	$2,126,947
5	RXRX	Recursion Pharmaceuticals, Inc.	669,568	$2,055,573
6	WVE	Wave Life Sciences Ltd.	282,719	$2,049,712
7	SRPT	Sarepta Therapeutics, Inc.	90,960	$1,979,289
8	IOVA	Iovance Biotherapeutics, Inc.	557,085	$1,955,368

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$326,766	194,504	-25.6%	Shares	Sole	2026-05-08
2025-12-31	$478,296	261,364	+6.0%	Shares	Sole	2026-02-06
2025-09-30	$535,267	246,667	+31.9%	Shares	Sole	2025-11-07
2025-06-30	$400,353	187,081	+177.7%	Shares	Sole	2025-07-22
2025-03-31	$113,872	67,380	-24.7%	Shares	Sole	2025-05-08
2024-12-31	$206,788	89,519	-30.0%	Shares	Sole	2025-02-07
2024-09-30	$251,899	127,868	+194.9%	Shares	Sole	2024-11-05
2024-06-30	$72,833	43,353	-35.4%	Shares	Sole	2024-08-15
2024-03-31	$127,476	67,093	+308.1%	Shares	Sole	2024-05-03
2023-12-31	$31,897	16,442	—	Shares	Sole	2024-02-16
No filing history on record for this holder in this stock.